News VolitionRx Limited

Equities

VNRX

US9286611077

Market Closed - Nyse Other stock markets 04:00:00 2024-06-04 pm EDT			5-day change	1st Jan Change
0.72 ^USD	-0.98%		+5.88%	+0.42%

May. 14	Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024
May. 13	VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024	May. 14
VolitionRX: Q1 Earnings Snapshot	May. 13	AQ
VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
VolitionRx Limited Announces Board Changes	Apr. 26	CI
VolitionRx Limited Launches In-Clinic in U.S. and Europe Through Antech	Apr. 23	CI
Transcript : VolitionRx Limited, Q4 2023 Earnings Call, Mar 26, 2024	Mar. 26
VolitionRx Limited announced that it has received $0.1 million in funding	Mar. 25	CI
VolitionRx Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 25	CI
North American Morning Briefing : Tech in Focus on -2-	Mar. 25	DJ
VolitionRx Limited Agrees Supply Agreement with Fujifilm Vet Systems Co. Ltd	Mar. 20	CI
VolitionRx Names Andrew Retter as Chief Medical Officer	Mar. 19	MT
Volitionrx Limited Appoints Andrew Retter as Chief Medical Officer, Effective April 1, 2024	Mar. 19	CI
VolitionRx Limited announced that it expects to receive $0.1 million in funding	Mar. 11	CI
Transcript : VolitionRx Limited - Special Call	Feb. 13
Sector Update: Health Care Stocks Gain Late Afternoon	Jan. 02	MT
Sector Update: Health Care	Jan. 02	MT
VolitionRX Shares Soar After $13.0 Million Milestone Payments From Heska	Jan. 02	MT
VolitionRx Limited Secures Approximately $5.5 Million in Belgium Regional Government Financing from Wallonie Entreprendre	Dec. 05	CI
VolitionRx Limited announced that it has received ?2.5 million in funding	Dec. 04	CI
Cantor Fitzgerald Adjusts Price Target on VolitionRX to $2.50 From $2.10, Maintains Overweight Rating	Nov. 16	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News VolitionRx Limited

Equities

VNRX

US9286611077

Summary

Filters